Literature DB >> 412935

Theophylline for treatment of asthma.

M Weinberger.   

Abstract

Theophylline has become useful not just as an acute bronchodilator, but also as a major prophylactic agent for the suppression of symptoms of chronic asthma. Efficacy and toxicity both relate closely to serum concentration. Variable elimination rates for the drug among individuals require careful individualization of dosage guided by measurement of serum theophylline concentration to maintain safe and effective serum theophylline concentrations. Fixed-dose combinations with ephedrine are more likely to add toxicity than benefit compared with theophylline alone if the latter is used in an adequate dose. Choices among the vase array of products available can be further simplified by considering cost and convenience of the various formulations. When used appropriately, theophylline has been successful in the essential elimination of asthmatic symptoms in over 70% of asthmatic children seen at a tertiary care referral center.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 412935     DOI: 10.1016/s0022-3476(78)80058-4

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  9 in total

Review 1.  Cost-effectiveness of therapeutic drug monitoring.

Authors:  S Vozeh
Journal:  Clin Pharmacokinet       Date:  1987-09       Impact factor: 6.447

Review 2.  Clinical pharmacokinetics of theophylline.

Authors:  R I Ogilvie
Journal:  Clin Pharmacokinet       Date:  1978 Jul-Aug       Impact factor: 6.447

3.  Comparison of IV salbutamol with IV aminophylline in severe acute asthma.

Authors:  I Blumenthal; W P Tormey
Journal:  Arch Dis Child       Date:  1979-12       Impact factor: 3.791

4.  Dose-titration comparison of inhaled salbutamol and oral theophylline in asthma.

Authors:  G E Marlin; M R Harris; J A Klumpp; J Rutland
Journal:  Br J Clin Pharmacol       Date:  1979-12       Impact factor: 4.335

5.  Errors in the treatment of asthma.

Authors:  H Guy
Journal:  Drugs       Date:  1980-02       Impact factor: 9.546

6.  Serum level monitoring of a new slow release theophylline formulation in patients with chronic lung disease.

Authors:  G E Marlin; M A Butcher; J A Klumpp; P J Thompson
Journal:  Br J Clin Pharmacol       Date:  1980-09       Impact factor: 4.335

7.  Influence of food intake on bioavailability of theophylline in premature infants.

Authors:  G Heimann; J Murgescu; U Bergt
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

8.  Bioavailability and diurnal variation in absorption of sustained release theophylline in asthmatic children.

Authors:  K P Coulthard; D J Birkett; D R Lines; N Grgurinovich; J J Grygiel
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

9.  Antigen-induced bronchial anaphylaxis in actively sensitized guinea-pigs: anti-anaphylactic effects of sodium cromoglycate and aminophylline.

Authors:  P Andersson
Journal:  Br J Pharmacol       Date:  1980-07       Impact factor: 8.739

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.